In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MedImmune Reaches for a Blockbuster

Executive Summary

MedImmune Inc. is reaching for a blockbuster through its acquisition of Aviron, whose nasally inhaled flu vaccine FluMist now seems close to winning FDA approval--perhaps in time for the 2002 flu season. Aviron has struggled to develop the product, particularly with regulatory and marketing issues that MedImmune has shown it can handle well.
Advertisement

Related Content

Biotech's Holiday Shopping Spree--Buy, Buy, Buy
Biotech's Holiday Shopping Spree--Buy, Buy, Buy

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV001578

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel